Skip to main content
Christian Rolfo, MD, Oncology, New York, NY

ChristianRolfoMDPhD, MBA, Dr.h.c.

Oncology • New York, NY

Thoracic Cancer

Professor & Associate Dir Clinical Research Center for Thoracic Onc , Tisch Cancer Inst. Icahn School of Medicine at Mount Sinai, New York

Join to view full profile

Dr. Rolfo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rolfo's full profile

Already have an account?

  • Office

    Tisch Cancer Institute, Center for Thoracic Oncology, Mount Sinai
    1176 Fifth Ave
    New York, NY 10029
    Phone+1 212-827-7227

Summary

  • SHARE: Open Share Modal Print
    Christian Rolfo, MD, PhD, MBA
    Professor of Medicine

    #
    Specialties:

    Medical Oncology

    About Education
    Toggle accordion item
    Christian Rolfo, MD, PhD, MBA is the director of the Thoracic Medical Oncology and the Early Clinical Trials at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). He specializes in thoracic oncology, drug development and translational oncology.

    Dr. Rolfo is also a professor in the Division of Hematology-Oncology at University of Maryland School of Medicine.

    Dr. Rolfo received his medical degree from the National University of Córdoba, Argentina in 1996. He completed his residency at University of Milan, Italy. He has earned certifications from the European Oncology Board and the Spanish and Belgian Board and spent an internship at MD Anderson Cancer Center in Houston.

    From 2012 to March 2018, Dr. Rolfo was senior staff for the Thoracic Oncology Cluster at the Antwerp University Hospital in Belgium. There he directed the Phase I ─ Early Clinical Trials Unit and the Clinical Trials Management Program.

    Dr. Rolfo actively works on drug development and resistance in lung cancer and mesothelioma treatment. His focus of research are liquid biopsies (exosomes and ctDNA) and molecular profling, he is involved in druggable biomarkers research and immunotherapy in thoracic cancer.

    Dr. Rolfo is on the educational Committee of the International Association for the Study of Lung Cancer (IASLC), Membership Committee of European Society of Medical Oncology (ESMO) and Educational Chair of the International Society of Liquid Biopsies(ISLB). He is a member of the American Society of Clinical Oncology (ASCO) and other societies.

    His work has been published in “New England Journal of Medicine,” “Lancet Oncology,” “Nature Nanotechnology,” “Lung Cancer” and other journals. Speaking engagements include global forums on lung cancer and drug develop

Education & Training

  • MD Anderson Cancer Center
    MD Anderson Cancer CenterInternship, 2013 - 2013
  • Polytechnic University of Valencia, Spain
    Polytechnic University of Valencia, SpainMBA, Health, 2008 - 2009
  • University of Palermo, Italy
    University of Palermo, ItalyPhD, Experimental Oncology, Cum Laude, 2006 - 2009
  • University of Milan, Italy
    University of Milan, ItalyFellowship, 2000 - 2003
  • Universidad Nacional de Cordoba
    Universidad Nacional de CordobaClass of 1996

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2020 - 2026
  • MD State Medical License
    MD State Medical License 2018 - 2021

Awards, Honors, & Recognition

  • Jean Dausset Award Royal College of Medicine, Balearic Islands, Spain, 2009

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Liquid Biopsy handbook1/1/2017

Press Mentions

  • Osimertinib plus Chemo Ups PFS, Toxicity in First Line
    Osimertinib plus Chemo Ups PFS, Toxicity in First LineSeptember 14th, 2023
  • Biomarker in Liquid Biopsy for Lung Cancer Can Be More Reliable Than Tumour Biopsy, Study Reveals
    Biomarker in Liquid Biopsy for Lung Cancer Can Be More Reliable Than Tumour Biopsy, Study RevealsJune 3rd, 2022
  • First Seven Days Spanish Language Podcast Gives Newly-Diagnosed Lung Cancer Patients Potentially Life-Saving Guidance from Lung Cancer Foundation of America
    First Seven Days Spanish Language Podcast Gives Newly-Diagnosed Lung Cancer Patients Potentially Life-Saving Guidance from Lung Cancer Foundation of AmericaSeptember 7th, 2021
  • Join now to see all

Committees

  • Vice-president, International Society of Liquid Biopsy 2019 - Present
  • Member, Membership committe ESMO 2018 - Present
  • Member, IALSC Education Committee 2017 - Present
  • Educational Chair, Oncology Latin American Society

Professional Memberships

Other Languages

  • Italian, Dutch, Portuguese, Spanish

External Links

Dr. Christian Rolfo, Dr. Christian Rolfo, MD, Dr. C Rolfo